SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
TransTech Pharma, Inc. Release: TTP054, a Novel, Orally Active Drug for Glucose Control, Progresses towards Completion of a Phase 2 Proof-of-Concept Clinical Trial in Type 2 Diabetics
Your Message